Stay updated on Velaglucerase Alfa for Type 1 Gaucher Clinical Trial

Sign up to get notified when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T07:59:23.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No other visible changes to the page content.
    Difference
    0.0%
    Check dated 2026-02-14T01:52:11.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T16:51:13.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Changes are limited to user interface text and metadata, including the addition of glossary show/hide options, capitalization tweaks to QC-related labels, and a new software revision tag. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-23T16:57:08.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page revision indicates an update from v3.3.3 to v3.3.4, a minor backend/format change that does not affect displayed study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-16T07:39:56.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a new Locations section listing study sites by state (Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Iowa, Maryland, Massachusetts, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Virginia) and included Revision: v3.3.3. Removed the previous state location blocks (Arizona Locations, California Locations, etc.) and the HHS Vulnerability Disclosure as part of Revision: v3.3.2.
    Difference
    2%
    Check dated 2025-12-18T21:51:10.000Z thumbnail image

Stay in the know with updates to Velaglucerase Alfa for Type 1 Gaucher Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.